Pfe stock forecast 2025.

Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $187.28B. -23.7%. Market Cap / …

Pfe stock forecast 2025. Things To Know About Pfe stock forecast 2025.

Nov 22, 2023 · Pfizer Inc Stock Forecast 2023. In the last five quarters, Pfizer Inc’s Price Target has fallen from $57.79 to $40.55 - a -29.83% decrease. Eight analysts predict that Pfizer Inc’s share price will fall in the coming year, reaching $37.50. This would represent a decrease of -7.52%. May 16, 2023 07:15 PM Eastern Daylight Time. NEW YORK-- ( BUSINESS WIRE )--Pfizer Inc. (NYSE:PFE) (“Pfizer”) today announced the pricing of a debt offering consisting of eight tranches of ...With nine first-in-class launches expected by 2025, we expect minimal revenue impact for PFE's patent cliff from 2025 onwards.$163B Today's Change (-5.12%) -$1.56 Current Price $28.91 Price as of December 1, 2023, 4:00 p.m. ET A prediction: In a much better position than it has been …Dec 1, 2023 · According to the issued ratings of 17 analysts in the last year, the consensus rating for Pfizer stock is Hold based on the current 11 hold ratings and 6 buy ratings for PFE. The average twelve-month price prediction for Pfizer is $42.50 with a high price target of $75.00 and a low price target of $33.00. Learn more on PFE's analyst rating history.

SmartAssetPaid Partner. Find real-time PFE - Pfizer Inc stock quotes, company profile, news and forecasts from CNN Business. The bulls and bears were battling all day. But there's nothing new about that. PFE stock has been choppy for the better part of the year. It’s down 16% in the last 12 months. And despite today ...Read this article to know why I think PFE stock makes for a quite reasonable investment. ... according to management's guidance, but the forecast adjusted EPS of $3.25 - $3.45 offers a forward PE ...

Dec 2, 2023 · Procter & Gamble Fair Value Forecast for 2023 - 2025 - 2030. Procter & Gamble's Price has grown In the last four years, rising from $112.91 to $147.38 – a growth of 30.53%. In the next year, analysts believe that Fair Value will reach $170.11 – an increase of 15.42%. For the next seven years, experts predict that Procter & Gamble's Fair ...

Pfizer (PFE) stock forecast for 2023 The forecast has been updated: November 1, 2023 9:40. Pfizer stock price online today. Analyst Target Price. 44.38 . Dividend Date . ... 2025. 2026. 2027. PFE Forecast for 2023. Month Rate Forecast MIN Rate : MAX Rate Volati-lity, % Dec: 32.95: 31.32: 34.88:The Pfizer stock prediction for 2025 is currently $ 36.25, assuming that Pfizer shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 15.95% increase in the PFE stock price. The site’s Pfizer stock prediction saw the stock rising 8% to $55 over the coming year. Its Pfizer stock forecast for 2025 put the stock at $61.35, while the five year forecast to June 2027 sees the price at $67.6. This would be a 33% premium over the $50.94 closing price on 29 June 2022. Note that analysts’ predictions can be wrong.Find real-time PPG - PPG Industries Inc stock quotes, company profile, news and forecasts from CNN Business.

Oct 11, 2023 · Optimistic: 47.39. Pfizer stock forecast for Aug 2025. Estimated Average Forecasted Pfizer Price: 45.91. Positive monthly dynamics of the instrument is expected with 9.281% volatility is expected.

Research Pfizer's (NYSE:PFE) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... Earnings are forecast to grow 19.23% per year. Trading at good value compared to peers and industry. Risk Analysis. Profit margins (15.3%) are lower than last year (30%)

Results 1 - 100 of 280 ... On an annual basis, our forecast for 2022 GDP growth is 3.4%. Our estimates are a bit lower than other forecasters. The Federal Reserve ...Research Pfizer's (NYSE:PFE) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... Earnings are forecast to grow 19.23% per year. Trading at good value compared to peers and industry. Risk Analysis. Profit margins (15.3%) are lower than last year (30%)common stock. No share repurchases have been completed to date in 2023. As of May 2, 2023, Pfizer’s remaining share repurchase authorization is $3.3 billion. Current financial guidance does not anticipate any share repurchases in 2023. First-quarter 2023 diluted weighted-average shares outstanding used to calculate Reported(2) and Adjusted(3)Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $173.97 target price for Zscaler stock stock. Today 200 Day Moving Average is the resistance level (127.36 $). 50 Day Moving Average is the resistance level (147.04 $). 2023.Research Pfizer's (NYSE:PFE) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ... Earnings are forecast to grow 19.23% per year. Trading at good value compared to peers and industry. Risk Analysis. Profit margins (15.3%) are lower than last year (30%)Analysts are calling for sales growth of 3.5% this fiscal year, and while next year's estimated revenue growth of 1.4% is far from thrilling, bear in mind the company's developed something of a ...Moderna will start 2025 at $99.88, then soar to $100.71 within the first six months of the year and finish 2025 at $113.03. That means +41% from today. Moderna Stock Forecast 2030-2034. In this period, the Moderna price would rise from $201.67 to $252.73, which is +25%.

The average PFE price target is $47.57 per share, implying 6.1% upside potential from current levels. Bottom Line. Besides the growth potential, PFE stock also has an annualized dividend of $1.56 ...About the Pfizer Inc. stock forecast. As of 2023 November 30, Thursday current price of PFE stock is 30.080$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).AT&T Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 16.48. Negative dynamics for AT&T shares will prevail with possible volatility of 1.632%. Pessimistic target level: 16.40. Optimistic target level: 16.67.Next quarter’s sales forecast for INSG is $55.26M with a range of $54.10M to $56.67M. The previous quarter’s sales results were $53.56M. INSG beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 61.60% of the time in the same period. In the last calendar year INSG has Outperformed ...PEP Stock 12 Months Forecast. $189.67. (12.82% Upside) Based on 19 Wall Street analysts offering 12 month price targets for PepsiCo in the last 3 months. The average price target is $189.67 with a high forecast of $210.00 and a low forecast of $172.00. The average price target represents a 12.82% change from the last price of $168.11.SmartAssetPaid Partner. Find real-time PFE - Pfizer Inc stock quotes, company profile, news and forecasts from CNN Business.According to the issued ratings of 17 analysts in the last year, the consensus rating for Pfizer stock is Hold based on the current 11 hold ratings and 6 buy ratings for PFE. The average twelve-month price prediction for Pfizer is $42.50 with a high price target of $75.00 and a low price target of $33.00. Learn more on PFE's analyst rating history.

Pfizer Stock Forecast 31 Oct. Presumably, on 10/31/2023, the price of shares will be in the range of $28.97 - $30.45. A $1.48 range width can provide 5.10% volatility. The weighted average price of this range is at $29.74, which is $0.05 higher than the previous day's weighted average price.

Read more about PFE stock and these five blue-chip bargains. ... that is expected to see peak sales of $7.4 billion in 2025. And then a 2026 patent cliff means sales by 2028 are expected to fall ...Read this article to know why I think PFE stock makes for a quite reasonable investment. ... according to management's guidance, but the forecast adjusted EPS of $3.25 - $3.45 offers a forward PE ...Jun 29, 2023 · Credit Suisse downgrades Pfizer, says pharma giant will struggle to keep up with competitors. Published Thu, Jun 29 20237:06 AM EDT Updated Thu, Jun 29 202311:59 AM EDT. Alex Harring @alex_harring. Credit Suisse downgrades Pfizer, says pharma giant will struggle to keep up with competitors. Published Thu, Jun 29 20237:06 AM EDT Updated Thu, Jun 29 202311:59 AM EDT. Alex Harring @alex_harring.Most investors who have been following Pfizer ( PFE 0.59%) for awhile can't be overly pleased with how it has fared over the last five years. The big drugmaker badly underperformed the S&P 500 ...Stock price predictions. Stock price predictions, forecasts with 14 days, 3 months, 6 months, 1 year and 5 years timeline. Name 14d Forecast 3m Forecast 6m Forecast 1y Forecast 5y Forecast; JPMorgan BetaBuilders Canada ETF (BBCA) 0.845 %: 18.344 %: 14.454 %: 125.671 %: 1000+ % Nuveen Georgia ...Two Harbors Investment Corp () Stock Market info Recommendations: Buy or sell Two Harbors Investment stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Two Harbors Investment share forecasts, stock quote and buy / sell signals below.According to present data Two Harbors Investment's TWO shares and …Dec 22, 2021 · Investment Thesis. In FY2021 YTD, Pfizer Inc. ( NYSE: PFE) recorded a total of $24.27B of revenue from its Comirnaty sales. For FY2021, PFE is expecting a record-breaking total revenue of $82B ...

1 Day PFE -5.12% DJIA 0.82% S&P 500 0.59% Health Care/Life Sciences -0.13% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Analysts are calling for sales growth of 3.5% this fiscal year, and while next year's estimated revenue growth of 1.4% is far from thrilling, bear in mind the company's developed something of a ...

Nov 24, 2023 · According to 3 stock analysts, the average 12-month stock price forecast for Pyxis Oncology stock is $12, which predicts an increase of 674.19%. The lowest target is $7.00 and the highest is $15. On average, analysts rate Pyxis Oncology stock as a strong buy. Vertex Pharmaceuticals Inc Revenue Forecast for 2023 - 2025 - 2030. In the last three years, Revenue for Vertex Pharmaceuticals Inc has grown by 114.54%, going from $4.16B to $8.93B. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach $9.24B – an increase of 3.42%. Over the next eight years, experts ...Pfizer Inc. (PFE) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts.Dec 9, 2022 · The performance of Pfizer can be bullish in 2025 but it will hardly touch the recent ATH. By 2025, we may expect an average price of $78.53 for Pfizer stock. If current growth continues, our maximum forecast for Pfizer is $85.75 in 2025. The minimum price level of Pfizer can be around $71.86 if the market turns bearish. I tend to agree with the sales forecast for 2022 thru 2025. Therefore, PFE appears to have momentum to achieve 20-30% upside potential in 2022 and will most likely fall back to the current level ...Ares Capital Stock Forecast, ARCC stock price prediction. Price target in 14 days: 20.058 USD. The best long-term & short-term Ares Capital share price prognosis for 2023, 2024, 2025, ... Ares Capital Corp Stock Price Forecast …Vertex Pharmaceuticals Inc Revenue Forecast for 2023 - 2025 - 2030. In the last three years, Revenue for Vertex Pharmaceuticals Inc has grown by 114.54%, going from $4.16B to $8.93B. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach $9.24B – an increase of 3.42%. Over the next eight years, experts ...See Pfizer Inc. (PFE) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Oct 16, 2023 · Pfizer stock falls after company slashes $9 billion from sales outlook ... PFE-5.12%. BNTX-1.01%. SPX ... Pfizer forecast in August full-year earnings of $3.25 to $3.45 a share on revenue of $67 ... About the PepsiCo, Inc. stock forecast. As of 2023 November 27, Monday current price of PEP stock is 169.330$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. PepsiCo stock price has been showing a declining tendency so we believe that similar market segments were not very …

Pfizer (PFE) Stock Price & Analysis · Pfizer Stock Smart Score · Pfizer News · Company Description · Top 5 ETFs holding PFE · Forecast EPS vs Actual EPS · Financials.Q1 2024 EPS Estimate Trends. Current. $0.91. 1 Month Ago. $0.90. 3 Months Ago. $0.98. Pfizer Inc. analyst estimates, including PFE earnings per share estimates and analyst recommendations. Dec 9, 2022 · The performance of Pfizer can be bullish in 2025 but it will hardly touch the recent ATH. By 2025, we may expect an average price of $78.53 for Pfizer stock. If current growth continues, our maximum forecast for Pfizer is $85.75 in 2025. The minimum price level of Pfizer can be around $71.86 if the market turns bearish. Instagram:https://instagram. same day debit card bankscadillac celestigbest stock broker ukhoneywell forge PFE: Get the latest Pfizer stock price and detailed information including PFE news, historical charts and realtime prices. Indices Commodities Currencies StocksPfizer, Inc. (PFE.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Pfizer, Inc. | Nyse: PFE | Nyse primecap vanguardai forecast In 2025, PFE is forecast to generate $19,480,125,857 in earnings, with the lowest earnings forecast at $17,390,952,939 and the highest earnings forecast at $22,924,437,966. ... Wall Street analysts that have issued a 1 year PFE price target, the average PFE price target is $40.67, with the highest PFE stock price forecast at $75.00 and the ... stocks with low float Pfizer stock (NYSE: PFE) currently trades at $37 per share, aligning with the level seen in March 2021, and it can see higher levels over time. PFE stock was trading at around $52 in early...Most investors who have been following Pfizer ( PFE 0.59%) for awhile can't be overly pleased with how it has fared over the last five years. The big drugmaker badly underperformed the S&P 500 ...